STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells
Authors
Keywords
Apoptosis, Ovarian cancer, Autophagic cell death, Transfection, Nanoparticles, Fluorescence microscopy, Lipids, Nucleic acids
Journal
PLoS One
Volume 10, Issue 4, Pages e0124924
Publisher
Public Library of Science (PLoS)
Online
2015-04-30
DOI
10.1371/journal.pone.0124924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial–mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling
- (2014) Myung-Jin Kim et al. CANCER LETTERS
- STAT3 Oligonucleotide Inhibits Tumor Angiogenesis in Preclinical Models of Squamous Cell Carcinoma
- (2014) Jonah D. Klein et al. PLoS One
- Systemic Delivery of microRNA-34a for Cancer Stem Cell Therapy
- (2013) Sanjun Shi et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cationic lipid nanosystems as carriers for nucleic acids
- (2013) Rita Cortesi et al. New Biotechnology
- Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer
- (2013) Minal Garg World Journal of Stem Cells
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
- (2012) Jiehui Deng et al. CANCER CELL
- Targeting STAT3 in gastric cancer
- (2012) Andrew S Giraud et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cell and Gene Therapy for Genetic Diseases: Inherited Disorders Affecting the Lung and Those Mimicking Sudden Infant Death Syndrome
- (2012) Allison M. Keeler et al. HUMAN GENE THERAPY
- Gene therapy for brain tumors: Basic developments and clinical implementation
- (2012) Hikmat Assi et al. NEUROSCIENCE LETTERS
- A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB
- (2011) Inès Souissi et al. BMC CELL BIOLOGY
- Solid Lipid Nanoparticles Loaded with Anti-microRNA Oligonucleotides (AMOs) for Suppression of MicroRNA-21 Functions in Human Lung Cancer Cells
- (2011) San-Jun Shi et al. PHARMACEUTICAL RESEARCH
- Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells
- (2010) Xiaolei Zhang et al. CANCER GENETICS AND CYTOGENETICS
- Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery
- (2009) Wangyang Yu et al. NANOTECHNOLOGY
- Stat3 Expression and Its Correlation with Proliferation and Apoptosis/Autophagy in Gliomas
- (2009) Valentina Caldera et al. Journal of Oncology
- Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN
- (2008) Xiaoxia Sun et al. CANCER LETTERS
- Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells
- (2008) Jinhai Gu et al. JOURNAL OF NEURO-ONCOLOGY
- Anionic solid lipid nanoparticles supported on protamine/DNA complexes
- (2008) Jiesheng Ye et al. NANOTECHNOLOGY
- Ovarian Cancer
- (2008) Nishan Chobanian et al. SURGICAL CLINICS OF NORTH AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More